Leaflet INFANRIX PENTA injection suspension

Product code:
W13419010
Quantity:
10
Indicated for:
active immunization
Route of administration:
injectable
ATC
J07CAN1 — Antiinfectives for systemic use | Bacterial and viral vaccines, combined

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage

Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light

Protect from light

Store protected from light.

The combined DTP+HBV+IPV vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and poliomyelitis. This vaccine contains components of Bordetella pertussis, diphtheria and tetanus toxoids, the hepatitis B surface antigen, and inactivated polioviruses.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as poliomyelitis, chronic hepatitis B, and complications associated with diphtheria, tetanus, and whooping cough.

Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.

The combined DTP+HBV+IPV vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.

General data about INFANRIX PENTA

Substance:
DTP + HBV + IPV combination vaccine
Date of latest medicines list:
01-07-2013
Product code:
W13419010
Pharmaceutical form:
injection suspension
Quantity:
10
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.